UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048253
Receipt number R000054996
Scientific Title Effect of Steroid Dose in Hematopoietic Stem Cell Transplantation on Standing and Stair Climbing
Date of disclosure of the study information 2022/07/04
Last modified on 2023/07/04 09:31:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Steroid Dose in Hematopoietic Stem Cell Transplantation on Standing and Stair Climbing

Acronym

Effect of Steroid Dose in Hematopoietic Stem Cell Transplantation on Standing and Stair Climbing

Scientific Title

Effect of Steroid Dose in Hematopoietic Stem Cell Transplantation on Standing and Stair Climbing

Scientific Title:Acronym

Effect of Steroid Dose in Hematopoietic Stem Cell Transplantation on Standing and Stair Climbing

Region

Japan


Condition

Condition

Hematopoietic stem cell transplant patients

Classification by specialty

Hematology and clinical oncology Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A study conducted at our hospital reported that steroid myopathy is caused by the administration of large doses of steroids to prevent graft-versus-host disease after hematopoietic stem cell transplantation.
Steroid myopathy is characterized by a predominant decrease in fast-twitch muscle fibers, and muscle weakness is often seen in the quadriceps and tibialis anterior muscles, which have a high ratio of fast-twitch muscle fibers.
Therefore, many patients after HSCT experience difficulty in standing up and walking up and down stairs, which require strength of the quadriceps muscle in particular.
No previous study has investigated the relationship between steroid dosage and the ability to stand up and climb stairs in HSCT patients.
We believe that clarifying the actual status of these impaired movement abilities will motivate patients to practice movement and strengthen their muscles at an early stage.
The purpose of this study was to clarify the relationship between steroid dosage and changes in ability to stand up and climb stairs, muscle strength, and skeletal muscle mass before and after HSCT in HSCT patients with the aim of proposing items associated with decreased movement ability.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

30-second chair rise test (evaluated before transplantation, after engraftment (approximately 3 weeks after transplantation), and at discharge)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients 18 years of age or older who are scheduled for hematopoietic stem cell transplantation and request physical therapy at this hospital.

Key exclusion criteria

Patients with severe cardiac disease, bone tumors with a risk of fracture, patients with unrelated diseases that make it difficult to assess lower limb function, patients in poor general condition that makes it difficult to assess physical function, patients with unsuccessful transplants such as failure of implantation, and relapsed cases.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Nobuyoshi
Middle name
Last name Nishikado

Organization

Hyogo Medical University Hospital

Division name

rehabilitation

Zip code

6638501

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

TEL

0798456111

Email

nnishikado@gmail.com


Public contact

Name of contact person

1st name Nobuyoshi
Middle name
Last name Nishikado

Organization

Hyogo Medical University Hospital

Division name

rehabilitation

Zip code

6638501

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

TEL

0798456111

Homepage URL


Email

nnishikado@gmail.com


Sponsor or person

Institute

Hyogo Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

MEXT

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo Medical University Hospital

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

Tel

0798456111

Email

unknown


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 06 Month 20 Day

Date of IRB

2022 Year 06 Month 20 Day

Anticipated trial start date

2022 Year 06 Month 20 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective observational study


Management information

Registered date

2022 Year 07 Month 03 Day

Last modified on

2023 Year 07 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054996